Haleon plc
HLN
Kedudukan dalam Saham
#13724
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Harga Saham
$5.08
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$447.23M
Perubahan (1 hari)
-0.11%
Perubahan (1 tahun)
7.96%
Negara
GB
Perdagangan Haleon plc (HLN)
Kategori
Healthcare
Modal pasaran bagi Haleon plc(HLN)
Modal Pasaran: $447.23M
Sehingga October 2026, Haleon plc mempunyai modal pasaran sebanyak $447.23M. Ini menjadikan Haleon plc syarikat ke-13724th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Haleon plc dari 2022 hingga 2026
